Page last updated: 2024-10-18

dihydroxyphenylalanine and Malignant Carcinoid Syndrome

dihydroxyphenylalanine has been researched along with Malignant Carcinoid Syndrome in 10 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19908 (80.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
COLLINI, FJ1
SJOERDSMA, A1
OATES, JA1
ZALTZMAN, P1
UDENFRIEND, S1
DAVIS, RB1
ALEXANDER, CS1
ADICOFF, A1
DUBACH, UC1
BLUMBERG, A1
WELTI, JJ1
DREUX, C1
BONVARLET, A1
SAVIER, CH1
DUHAMEL, J1
NICHOLSON, GI1
IRVINE, RO1
NOBLE, NR1
Koopmans, KP1
Brouwers, AH1
De Hooge, MN1
Van der Horst-Schrivers, AN1
Kema, IP1
Wolffenbuttel, BH1
De Vries, EG1
Jager, PL1
Nataf, V1
Balard, M1
de Beco, V1
Kerrou, K1
Gutman, F1
Grahek, D1
Montravers, F1
Talbot, JN1
Feldman, JM1
Butler, SS1
Chapman, BA1

Other Studies

10 other studies available for dihydroxyphenylalanine and Malignant Carcinoid Syndrome

ArticleYear
Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.
    The New England journal of medicine, 1961, May-11, Volume: 264

    Topics: Dihydroxyphenylalanine; Disease Management; Humans; Lyases; Malignant Carcinoid Syndrome; Methyldopa

1961
Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
    The New England journal of medicine, 1960, Sep-22, Volume: 263

    Topics: 5-Hydroxytryptophan; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Mal

1960
Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency.
    Metabolism: clinical and experimental, 1961, Volume: 10

    Topics: Dihydroxyphenylalanine; Humans; Isoniazid; Malignant Carcinoid Syndrome; Methyldopa; Serotonin; Tryp

1961
[On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].
    Klinische Wochenschrift, 1961, Sep-15, Volume: 39

    Topics: Dihydroxyphenylalanine; Humans; Malignant Carcinoid Syndrome; Methyldopa

1961
[Trial treatment of 2 cases of carcinoid syndrome with alpha-methyl-dopa].
    Bulletins et memoires de la Societe medicale des hopitaux de Paris, 1962, Volume: 113

    Topics: Dihydroxyphenylalanine; Humans; Malignant Carcinoid Syndrome; Methyldopa

1962
Effect of methyldopa in carcinoid disease.
    British medical journal, 1962, Oct-13, Volume: 2, Issue:5310

    Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Malignant Carcinoid Synd

1962
A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
    The Medical journal of Australia, 1961, Oct-07, Volume: 48(2)

    Topics: Dihydroxyphenylalanine; Humans; Malignant Carcinoid Syndrome; Methyldopa

1961
Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:7

    Topics: Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Liver N

2005
Safety of 18F-DOPA injection for PET of carcinoid tumor.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10

    Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Injections, Intravenous; Ma

2006
Interference with measurement of 3-methoxy-4-hydroxymandelic acid and 5-hydroxyindoleacetic acid by reducing metabolites.
    Clinical chemistry, 1974, Volume: 20, Issue:5

    Topics: Aged; Alkaptonuria; Aspirin; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Humans; Indoleacetic A

1974